Sales : +917069661818
Sign In
Register Now
Sample Tenders

tender for system suitability test solution acarbose , acyclovir , amorolfine hcl , atazanavir sulphate , atenolol , beclomethasone dipropionate , bromocriptine , bromhexine , buprenorphine hcl , carvedilol tablet , chlorhexidine , clindamycin phophate , clobetasol propionate , colchicine , dolutegravir sodium , domperidone , doxycycline hcl , duloxetine , ethambutol , famotidine , finasteride , fingolimod , flurbiprofen , fusidic acid , glimepride , griserfulvin , hysoscine butyl bromide , imatinib , ketoconazole , lincomycin , loratadine , minocycline hcl , mometasone furoate , morphine , naloxone , norfloxacin , nortriptyline hcl , oxytetracycline , perindopril erbumine , pilocarpine hcl , prednisolone , progesterone , rocuronium bromide , rosuvastatin , rupatadine fumarate , salbutamol , sumatriptan , tamoxifen citrate , thiamine , tibolone , dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets , tiotropium , triamcinolone acetonide , vancomycin , venlafaxime , zuclopenthixol decanoate, system suitability test solution, containing impurity a b c d e f and g, containing impurity b j k n o and p, containing impurity d e i and j, containing impurity rs ss diastreomer special repair ss diastrreomer, containing impurity b f g i and h, containing impurity a b c l and m, containing impurity a and b, containing impurity c and d, containing impurity a b f g h and j, containing impurity a and d, sst mixture, containing impurity b e f g i j k and l, containing impurity a b d and e, containing impurity a e and g, containing dolutegravir 4-fluro impurity isomer 1 isomer 2 and enantiomer, for peak identification containing dolutegravir sodium and impurity a b and d, containing impurity a and d plus e, containing impurity a b c and f, containing impurity f, containing rs isomer, containing impurity a b c d e f and g, for peak identification containing impurity a and c, containing impurity mixture a mixture containing fingolimod hydrochloride fingolimod hexyl homolog fingolimod heptyl homolog o-acetyl fingolimod fingolimod nonyl homolog fingolimod decyl homolog 3-phenethyl fingolimod analog and 2-phenethyl fingolimod analog, containing impurity b, for peak identification containing impurity a b c d f g h and n, for impurity mixture containing impurity i k l and m, containing impurity b c and d, containing impurity a b and c, containing impurity a, containing impurity a b c d and j, impurity mixture containing impurity c and d, containing impurity a and e, containing impurity a b c e f g and h, containing impurity c and j, containing impurity b c e and f, for peak identification containing impurity a b c d e and f, containing impurity a e and h, containing impurity d, containing impurity a b c d and e, for peak identification containing impurity b e f h and k, for peak identification containing impurity f and j, for peak identification containing impurity b c g i and m, for peak identification containing impurity a b c f g and h, containing impurity mixture a mixture containing rosuvastatin calcium rosuvastatin ketone rosuvastatin lactone and rosuvastatin diastereomers, for peak identification containing impurity c f n o and p, containing impurity a and h, for peak performance test iprs containing impurity a and f, impurity standard (containing b c and 1 percent weight by weight impurity a, containing impurity i and h, impurity mixture containing impurity g and h, containing impurity b and c, containing impurity a b c j k and m, containing impurity d and f

Latest Tender Detail from indian pharmacopoeia commission IPC for the tender for system suitability test solution acarbose , acyclovir , amorolfine hcl , atazanavir sulphate , atenolol , beclomethasone dipropionate , bromocriptine , bromhexine , buprenorphine hcl , carvedilol tablet , chlorhexidine , clindamycin phophate , clobetasol propionate , colchicine , dolutegravir sodium , domperidone , doxycycline hcl , duloxetine , ethambutol , famotidine , finasteride , fingolimod , flurbiprofen , fusidic acid , glimepride , griserfulvin , hysoscine butyl bromide , imatinib , ketoconazole , lincomycin , loratadine , minocycline hcl , mometasone furoate , morphine , naloxone , norfloxacin , nortriptyline hcl , oxytetracycline , perindopril erbumine , pilocarpine hcl , prednisolone , progesterone , rocuronium bromide , rosuvastatin , rupatadine fumarate , salbutamol , sumatriptan , tamoxifen citrate , thiamine , tibolone , dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets , tiotropium , triamcinolone acetonide , vancomycin , venlafaxime , zuclopenthixol decanoate, system suitability test solution, containing impurity a b c d e f and g, containing impurity b j k n o and p, containing impurity d e i and j, containing impurity rs ss diastreomer special repair ss diastrreomer, containing impurity b f g i and h, containing impurity a b c l and m, containing impurity a and b, containing impurity c and d, containing impurity a b f g h and j, containing impurity a and d, sst mixture, containing impurity b e f g i j k and l, containing impurity a b d and e, containing impurity a e and g, containing dolutegravir 4-fluro impurity isomer 1 isomer 2 and enantiomer, for peak identification containing dolutegravir sodium and impurity a b and d, containing impurity a and d plus e, containing impurity a b c and f, containing impurity f, containing rs isomer, containing impurity a b c d e f and g, for peak identification containing impurity a and c, containing impurity mixture a mixture containing fingolimod hydrochloride fingolimod hexyl homolog fingolimod heptyl homolog o-acetyl fingolimod fingolimod nonyl homolog fingolimod decyl homolog 3-phenethyl fingolimod analog and 2-phenethyl fingolimod analog, containing impurity b, for peak identification containing impurity a b c d f g h and n, for impurity mixture containing impurity i k l and m, containing impurity b c and d, containing impurity a b and c, containing impurity a, containing impurity a b c d and j, impurity mixture containing impurity c and d, containing impurity a and e, containing impurity a b c e f g and h, containing impurity c and j, containing impurity b c e and f, for peak identification containing impurity a b c d e and f, containing impurity a e and h, containing impurity d, containing impurity a b c d and e, for peak identification containing impurity b e f h and k, for peak identification containing impurity f and j, for peak identification containing impurity b c g i and m, for peak identification containing impurity a b c f g and h, containing impurity mixture a mixture containing rosuvastatin calcium rosuvastatin ketone rosuvastatin lactone and rosuvastatin diastereomers, for peak identification containing impurity c f n o and p, containing impurity a and h, for peak performance test iprs containing impurity a and f, impurity standard (containing b c and 1 percent weight by weight impurity a, containing impurity i and h, impurity mixture containing impurity g and h, containing impurity b and c, containing impurity a b c j k and m, containing impurity d and f in ghaziabad, uttar pradesh,. Reference number 15861637. Don't miss out on this chance to be part of a significant project. Register for free today to access the complete tender details and download the necessary documents. Seize the opportunity with Tender 18!

Tender Basic Details
Download Document
T18 Ref No:15861637
Tender ID:GEM/2026/B/7668664
Tender Agency:indian pharmacopoeia commission IPC
City:ghaziabad
State:uttar pradesh
Tender Related Keywords :tenofovir disoproxil fumarate, buprenorphine, domperidone, doxycycline, norfloxacin, atazanavir, bromhexine, lamivudine, atenolol
Description :total quantity = 11600 ----- document required from seller = experience criteria,past performance,bidder turnover,certificate (requested in atc),oem authorization certificate,oem annual turnover,compliance of boq specification and supporting document ----- evaluation method = item wise evaluation
Key Values and Dates
Tender Value:Refer Document
Tender EMD:Refer Document
Tender Fee:Refer Document
Published Date:Jun 16, 2026
Due Date:Jul 07, 2026
Tender Opening Date:Jul 07, 2026
Tender Documents
Tender DocumentsDownload Document
Disclaimer
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
Tender Inquiry

This Government Tender has been Published  by Indian pharmacopoeia commission IPC for work related to tenofovir disoproxil fumarate,buprenorphine,domperidone,doxycycline,norfloxacin,atazanavir,bromhexine,lamivudine,atenolol in Ghaziabad, Uttar pradesh. The Tender work is tender for system suitability test solution acarbose , acyclovir , amorolfine hcl , atazanavir sulphate , atenolol , beclomethasone dipropionate , bromocriptine , bromhexine , buprenorphine hcl , carvedilol tablet , chlorhexidine , clindamycin phophate , clobetasol propionate , colchicine , dolutegravir sodium , domperidone , doxycycline hcl , duloxetine , ethambutol , famotidine , finasteride , fingolimod , flurbiprofen , fusidic acid , glimepride , griserfulvin , hysoscine butyl bromide , imatinib , ketoconazole , lincomycin , loratadine , minocycline hcl , mometasone furoate , morphine , naloxone , norfloxacin , nortriptyline hcl , oxytetracycline , perindopril erbumine , pilocarpine hcl , prednisolone , progesterone , rocuronium bromide , rosuvastatin , rupatadine fumarate , salbutamol , sumatriptan , tamoxifen citrate , thiamine , tibolone , dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets , tiotropium , triamcinolone acetonide , vancomycin , venlafaxime , zuclopenthixol decanoate, system suitability test solution, containing impurity a b c d e f and g, containing impurity b j k n o and p, containing impurity d e i and j, containing impurity rs ss diastreomer special repair ss diastrreomer, containing impurity b f g i and h, containing impurity a b c l and m, containing impurity a and b, containing impurity c and d, containing impurity a b f g h and j, containing impurity a and d, sst mixture, containing impurity b e f g i j k and l, containing impurity a b d and e, containing impurity a e and g, containing dolutegravir 4-fluro impurity isomer 1 isomer 2 and enantiomer, for peak identification containing dolutegravir sodium and impurity a b and d, containing impurity a and d plus e, containing impurity a b c and f, containing impurity f, containing rs isomer, containing impurity a b c d e f and g, for peak identification containing impurity a and c, containing impurity mixture a mixture containing fingolimod hydrochloride fingolimod hexyl homolog fingolimod heptyl homolog o-acetyl fingolimod fingolimod nonyl homolog fingolimod decyl homolog 3-phenethyl fingolimod analog and 2-phenethyl fingolimod analog, containing impurity b, for peak identification containing impurity a b c d f g h and n, for impurity mixture containing impurity i k l and m, containing impurity b c and d, containing impurity a b and c, containing impurity a, containing impurity a b c d and j, impurity mixture containing impurity c and d, containing impurity a and e, containing impurity a b c e f g and h, containing impurity c and j, containing impurity b c e and f, for peak identification containing impurity a b c d e and f, containing impurity a e and h, containing impurity d, containing impurity a b c d and e, for peak identification containing impurity b e f h and k, for peak identification containing impurity f and j, for peak identification containing impurity b c g i and m, for peak identification containing impurity a b c f g and h, containing impurity mixture a mixture containing rosuvastatin calcium rosuvastatin ketone rosuvastatin lactone and rosuvastatin diastereomers, for peak identification containing impurity c f n o and p, containing impurity a and h, for peak performance test iprs containing impurity a and f, impurity standard (containing b c and 1 percent weight by weight impurity a, containing impurity i and h, impurity mixture containing impurity g and h, containing impurity b and c, containing impurity a b c j k and m, containing impurity d and f. Tender18 Provide this type Government Tender Information on daily basis.


This tender invites eligible contractors, suppliers, manufacturers, consultants, Startups, Msmes, traders and service providers to submit bids for the specified project, supply, service, or work requirement.


Before applying, interested bidders should review the tender scope, eligibility criteria, estimated contract value, important dates, technical requirements, reqired docuent list for bidder and bid submission instructions as per provided in the official tender documents. 


This Verified Information Provide By Tender18 in this page so Bidder Can Easiy  Understanding tender  requirements and bidders can prepare a compliant and competitive tender proposal.

To participate in the tender for system suitability test solution acarbose , acyclovir , amorolfine hcl , atazanavir sulphate , atenolol , beclomethasone dipropionate , bromocriptine , bromhexine , buprenorphine hcl , carvedilol tablet , chlorhexidine , clindamycin phophate , clobetasol propionate , colchicine , dolutegravir sodium , domperidone , doxycycline hcl , duloxetine , ethambutol , famotidine , finasteride , fingolimod , flurbiprofen , fusidic acid , glimepride , griserfulvin , hysoscine butyl bromide , imatinib , ketoconazole , lincomycin , loratadine , minocycline hcl , mometasone furoate , morphine , naloxone , norfloxacin , nortriptyline hcl , oxytetracycline , perindopril erbumine , pilocarpine hcl , prednisolone , progesterone , rocuronium bromide , rosuvastatin , rupatadine fumarate , salbutamol , sumatriptan , tamoxifen citrate , thiamine , tibolone , dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets , tiotropium , triamcinolone acetonide , vancomycin , venlafaxime , zuclopenthixol decanoate, system suitability test solution, containing impurity a b c d e f and g, containing impurity b j k n o and p, containing impurity d e i and j, containing impurity rs ss diastreomer special repair ss diastrreomer, containing impurity b f g i and h, containing impurity a b c l and m, containing impurity a and b, containing impurity c and d, containing impurity a b f g h and j, containing impurity a and d, sst mixture, containing impurity b e f g i j k and l, containing impurity a b d and e, containing impurity a e and g, containing dolutegravir 4-fluro impurity isomer 1 isomer 2 and enantiomer, for peak identification containing dolutegravir sodium and impurity a b and d, containing impurity a and d plus e, containing impurity a b c and f, containing impurity f, containing rs isomer, containing impurity a b c d e f and g, for peak identification containing impurity a and c, containing impurity mixture a mixture containing fingolimod hydrochloride fingolimod hexyl homolog fingolimod heptyl homolog o-acetyl fingolimod fingolimod nonyl homolog fingolimod decyl homolog 3-phenethyl fingolimod analog and 2-phenethyl fingolimod analog, containing impurity b, for peak identification containing impurity a b c d f g h and n, for impurity mixture containing impurity i k l and m, containing impurity b c and d, containing impurity a b and c, containing impurity a, containing impurity a b c d and j, impurity mixture containing impurity c and d, containing impurity a and e, containing impurity a b c e f g and h, containing impurity c and j, containing impurity b c e and f, for peak identification containing impurity a b c d e and f, containing impurity a e and h, containing impurity d, containing impurity a b c d and e, for peak identification containing impurity b e f h and k, for peak identification containing impurity f and j, for peak identification containing impurity b c g i and m, for peak identification containing impurity a b c f g and h, containing impurity mixture a mixture containing rosuvastatin calcium rosuvastatin ketone rosuvastatin lactone and rosuvastatin diastereomers, for peak identification containing impurity c f n o and p, containing impurity a and h, for peak performance test iprs containing impurity a and f, impurity standard (containing b c and 1 percent weight by weight impurity a, containing impurity i and h, impurity mixture containing impurity g and h, containing impurity b and c, containing impurity a b c j k and m, containing impurity d and f, bidders should first download and review all available tender documents. These documents generally include the Notice Inviting Tender (NIT), Bill of Quantities (BOQ), technical specifications, eligibility criteria, scope of work, and bid submission instructions.


Tender Governemnt Authorities like Indian pharmacopoeia commission IPC usually publish these documents on their official eProcurement portals, departmental tender portals, the GeM Tender Portal, or other government procurement platforms or on newspapre. Finding and accessing the correct tender documents across multiple portals can sometimes be time-consuming for bidders. 


To make the process easier, Tender18 provides quick access to the available tender documents related to this Ghaziabad , Uttar pradesh tender on a single page. Businesses involved in tenofovir disoproxil fumarate,buprenorphine,domperidone,doxycycline,norfloxacin,atazanavir,bromhexine,lamivudine,atenolol related products, services, or works can conveniently download the relevant documents and review the tender requirements without spending time searching across different procurement portals.

The tender for system suitability test solution acarbose , acyclovir , amorolfine hcl , atazanavir sulphate , atenolol , beclomethasone dipropionate , bromocriptine , bromhexine , buprenorphine hcl , carvedilol tablet , chlorhexidine , clindamycin phophate , clobetasol propionate , colchicine , dolutegravir sodium , domperidone , doxycycline hcl , duloxetine , ethambutol , famotidine , finasteride , fingolimod , flurbiprofen , fusidic acid , glimepride , griserfulvin , hysoscine butyl bromide , imatinib , ketoconazole , lincomycin , loratadine , minocycline hcl , mometasone furoate , morphine , naloxone , norfloxacin , nortriptyline hcl , oxytetracycline , perindopril erbumine , pilocarpine hcl , prednisolone , progesterone , rocuronium bromide , rosuvastatin , rupatadine fumarate , salbutamol , sumatriptan , tamoxifen citrate , thiamine , tibolone , dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets , tiotropium , triamcinolone acetonide , vancomycin , venlafaxime , zuclopenthixol decanoate, system suitability test solution, containing impurity a b c d e f and g, containing impurity b j k n o and p, containing impurity d e i and j, containing impurity rs ss diastreomer special repair ss diastrreomer, containing impurity b f g i and h, containing impurity a b c l and m, containing impurity a and b, containing impurity c and d, containing impurity a b f g h and j, containing impurity a and d, sst mixture, containing impurity b e f g i j k and l, containing impurity a b d and e, containing impurity a e and g, containing dolutegravir 4-fluro impurity isomer 1 isomer 2 and enantiomer, for peak identification containing dolutegravir sodium and impurity a b and d, containing impurity a and d plus e, containing impurity a b c and f, containing impurity f, containing rs isomer, containing impurity a b c d e f and g, for peak identification containing impurity a and c, containing impurity mixture a mixture containing fingolimod hydrochloride fingolimod hexyl homolog fingolimod heptyl homolog o-acetyl fingolimod fingolimod nonyl homolog fingolimod decyl homolog 3-phenethyl fingolimod analog and 2-phenethyl fingolimod analog, containing impurity b, for peak identification containing impurity a b c d f g h and n, for impurity mixture containing impurity i k l and m, containing impurity b c and d, containing impurity a b and c, containing impurity a, containing impurity a b c d and j, impurity mixture containing impurity c and d, containing impurity a and e, containing impurity a b c e f g and h, containing impurity c and j, containing impurity b c e and f, for peak identification containing impurity a b c d e and f, containing impurity a e and h, containing impurity d, containing impurity a b c d and e, for peak identification containing impurity b e f h and k, for peak identification containing impurity f and j, for peak identification containing impurity b c g i and m, for peak identification containing impurity a b c f g and h, containing impurity mixture a mixture containing rosuvastatin calcium rosuvastatin ketone rosuvastatin lactone and rosuvastatin diastereomers, for peak identification containing impurity c f n o and p, containing impurity a and h, for peak performance test iprs containing impurity a and f, impurity standard (containing b c and 1 percent weight by weight impurity a, containing impurity i and h, impurity mixture containing impurity g and h, containing impurity b and c, containing impurity a b c j k and m, containing impurity d and f from Ghaziabad, Uttar pradesh may be relevant for contractors, suppliers, vendors, manufacturers, consultants, service providers, startups, MSMEs, and other organizations involved in tenofovir disoproxil fumarate,buprenorphine,domperidone,doxycycline,norfloxacin,atazanavir,bromhexine,lamivudine,atenolol related products, services, or works. However, eligibility to participate depends on the qualification criteria specified by Indian pharmacopoeia commission IPC in the official tender documents.

Before submitting a bid, interested applicants should carefully review the eligibility conditions, technical requirements, financial criteria, work experience requirements, annual turnover conditions, registrations, certifications, and any other supporting documents required by the tendering authority. The detailed qualification requirements and bidder eligibility criteria are available in the tender notice and related documents provided on this page. 

Ensuring compliance with all eligibility and qualification requirements before bid submission can help bidders avoid disqualification and improve their chances of successful participation in the tender process.

Tende18 provides comprehensive tender bidding services, including a complete tender summary along with a detailed analysis of the Tender Qualification and Eligibility Criteria.

Interested in participating in the tender for system suitability test solution acarbose , acyclovir , amorolfine hcl , atazanavir sulphate , atenolol , beclomethasone dipropionate , bromocriptine , bromhexine , buprenorphine hcl , carvedilol tablet , chlorhexidine , clindamycin phophate , clobetasol propionate , colchicine , dolutegravir sodium , domperidone , doxycycline hcl , duloxetine , ethambutol , famotidine , finasteride , fingolimod , flurbiprofen , fusidic acid , glimepride , griserfulvin , hysoscine butyl bromide , imatinib , ketoconazole , lincomycin , loratadine , minocycline hcl , mometasone furoate , morphine , naloxone , norfloxacin , nortriptyline hcl , oxytetracycline , perindopril erbumine , pilocarpine hcl , prednisolone , progesterone , rocuronium bromide , rosuvastatin , rupatadine fumarate , salbutamol , sumatriptan , tamoxifen citrate , thiamine , tibolone , dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets , tiotropium , triamcinolone acetonide , vancomycin , venlafaxime , zuclopenthixol decanoate, system suitability test solution, containing impurity a b c d e f and g, containing impurity b j k n o and p, containing impurity d e i and j, containing impurity rs ss diastreomer special repair ss diastrreomer, containing impurity b f g i and h, containing impurity a b c l and m, containing impurity a and b, containing impurity c and d, containing impurity a b f g h and j, containing impurity a and d, sst mixture, containing impurity b e f g i j k and l, containing impurity a b d and e, containing impurity a e and g, containing dolutegravir 4-fluro impurity isomer 1 isomer 2 and enantiomer, for peak identification containing dolutegravir sodium and impurity a b and d, containing impurity a and d plus e, containing impurity a b c and f, containing impurity f, containing rs isomer, containing impurity a b c d e f and g, for peak identification containing impurity a and c, containing impurity mixture a mixture containing fingolimod hydrochloride fingolimod hexyl homolog fingolimod heptyl homolog o-acetyl fingolimod fingolimod nonyl homolog fingolimod decyl homolog 3-phenethyl fingolimod analog and 2-phenethyl fingolimod analog, containing impurity b, for peak identification containing impurity a b c d f g h and n, for impurity mixture containing impurity i k l and m, containing impurity b c and d, containing impurity a b and c, containing impurity a, containing impurity a b c d and j, impurity mixture containing impurity c and d, containing impurity a and e, containing impurity a b c e f g and h, containing impurity c and j, containing impurity b c e and f, for peak identification containing impurity a b c d e and f, containing impurity a e and h, containing impurity d, containing impurity a b c d and e, for peak identification containing impurity b e f h and k, for peak identification containing impurity f and j, for peak identification containing impurity b c g i and m, for peak identification containing impurity a b c f g and h, containing impurity mixture a mixture containing rosuvastatin calcium rosuvastatin ketone rosuvastatin lactone and rosuvastatin diastereomers, for peak identification containing impurity c f n o and p, containing impurity a and h, for peak performance test iprs containing impurity a and f, impurity standard (containing b c and 1 percent weight by weight impurity a, containing impurity i and h, impurity mixture containing impurity g and h, containing impurity b and c, containing impurity a b c j k and m, containing impurity d and f issued by Indian pharmacopoeia commission IPC for tenofovir disoproxil fumarate,buprenorphine,domperidone,doxycycline,norfloxacin,atazanavir,bromhexine,lamivudine,atenolol related work in Ghaziabad, Uttar pradesh? TENDER18 provides complete assistance to help businesses understand tender requirements, access tender documents, review eligibility criteria, qualification requirements, important dates, and bid submission guidelines associated with this tender.

Our Tender18 Expert Technical team can assist with vendor and GeM registration on the relevant departmental, eProcurement, GeM, or government tender portal, preparation of technical and financial bid documents, compliance with qualification criteria, document verification, and complete online tender submission support. Whether you are a contractor, supplier, manufacturer, consultant, startup, or MSME working in the field of tenofovir disoproxil fumarate,buprenorphine,domperidone,doxycycline,norfloxacin,atazanavir,bromhexine,lamivudine,atenolol, Tender18 can help simplify the tender participation process and support you throughout every stage of bidding for this tender. so that tender18 is one the top leading tender consultant in Inda.

1.
Whom should I contact if I have further queries about the Tender scope?

You can fill out the integrated inquiry form below on this detail page to share your company profile. Our consultancy desk will review your query regarding tenofovir disoproxil fumarate,buprenorphine,domperidone,doxycycline,norfloxacin,atazanavir,bromhexine,lamivudine,atenolol parameters and guide you on how to coordinate efficiently with the procurement team of Indian pharmacopoeia commission IPC

2.
How can Tender18 assist my business in winning this government contract?

Tender18 provides end-to-end professional bidding support and documentation advisory for tender for system suitability test solution acarbose , acyclovir , amorolfine hcl , atazanavir sulphate , atenolol , beclomethasone dipropionate , bromocriptine , bromhexine , buprenorphine hcl , carvedilol tablet , chlorhexidine , clindamycin phophate , clobetasol propionate , colchicine , dolutegravir sodium , domperidone , doxycycline hcl , duloxetine , ethambutol , famotidine , finasteride , fingolimod , flurbiprofen , fusidic acid , glimepride , griserfulvin , hysoscine butyl bromide , imatinib , ketoconazole , lincomycin , loratadine , minocycline hcl , mometasone furoate , morphine , naloxone , norfloxacin , nortriptyline hcl , oxytetracycline , perindopril erbumine , pilocarpine hcl , prednisolone , progesterone , rocuronium bromide , rosuvastatin , rupatadine fumarate , salbutamol , sumatriptan , tamoxifen citrate , thiamine , tibolone , dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets , tiotropium , triamcinolone acetonide , vancomycin , venlafaxime , zuclopenthixol decanoate, system suitability test solution, containing impurity a b c d e f and g, containing impurity b j k n o and p, containing impurity d e i and j, containing impurity rs ss diastreomer special repair ss diastrreomer, containing impurity b f g i and h, containing impurity a b c l and m, containing impurity a and b, containing impurity c and d, containing impurity a b f g h and j, containing impurity a and d, sst mixture, containing impurity b e f g i j k and l, containing impurity a b d and e, containing impurity a e and g, containing dolutegravir 4-fluro impurity isomer 1 isomer 2 and enantiomer, for peak identification containing dolutegravir sodium and impurity a b and d, containing impurity a and d plus e, containing impurity a b c and f, containing impurity f, containing rs isomer, containing impurity a b c d e f and g, for peak identification containing impurity a and c, containing impurity mixture a mixture containing fingolimod hydrochloride fingolimod hexyl homolog fingolimod heptyl homolog o-acetyl fingolimod fingolimod nonyl homolog fingolimod decyl homolog 3-phenethyl fingolimod analog and 2-phenethyl fingolimod analog, containing impurity b, for peak identification containing impurity a b c d f g h and n, for impurity mixture containing impurity i k l and m, containing impurity b c and d, containing impurity a b and c, containing impurity a, containing impurity a b c d and j, impurity mixture containing impurity c and d, containing impurity a and e, containing impurity a b c e f g and h, containing impurity c and j, containing impurity b c e and f, for peak identification containing impurity a b c d e and f, containing impurity a e and h, containing impurity d, containing impurity a b c d and e, for peak identification containing impurity b e f h and k, for peak identification containing impurity f and j, for peak identification containing impurity b c g i and m, for peak identification containing impurity a b c f g and h, containing impurity mixture a mixture containing rosuvastatin calcium rosuvastatin ketone rosuvastatin lactone and rosuvastatin diastereomers, for peak identification containing impurity c f n o and p, containing impurity a and h, for peak performance test iprs containing impurity a and f, impurity standard (containing b c and 1 percent weight by weight impurity a, containing impurity i and h, impurity mixture containing impurity g and h, containing impurity b and c, containing impurity a b c j k and m, containing impurity d and f . Our senior analysts help you decode the complete project guidelines, manage accurate costing sheets, and complete error-free submissions on the official platform used by Indian pharmacopoeia commission IPC.

3.
What are the main reasons for a technical tender rejection?

Most online bids face rejection during the initial evaluation round due to avoidable errors like uploading blurred document scans, submitting expired DSCs, or missing critical experience papers required for tender for system suitability test solution acarbose , acyclovir , amorolfine hcl , atazanavir sulphate , atenolol , beclomethasone dipropionate , bromocriptine , bromhexine , buprenorphine hcl , carvedilol tablet , chlorhexidine , clindamycin phophate , clobetasol propionate , colchicine , dolutegravir sodium , domperidone , doxycycline hcl , duloxetine , ethambutol , famotidine , finasteride , fingolimod , flurbiprofen , fusidic acid , glimepride , griserfulvin , hysoscine butyl bromide , imatinib , ketoconazole , lincomycin , loratadine , minocycline hcl , mometasone furoate , morphine , naloxone , norfloxacin , nortriptyline hcl , oxytetracycline , perindopril erbumine , pilocarpine hcl , prednisolone , progesterone , rocuronium bromide , rosuvastatin , rupatadine fumarate , salbutamol , sumatriptan , tamoxifen citrate , thiamine , tibolone , dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets , tiotropium , triamcinolone acetonide , vancomycin , venlafaxime , zuclopenthixol decanoate, system suitability test solution, containing impurity a b c d e f and g, containing impurity b j k n o and p, containing impurity d e i and j, containing impurity rs ss diastreomer special repair ss diastrreomer, containing impurity b f g i and h, containing impurity a b c l and m, containing impurity a and b, containing impurity c and d, containing impurity a b f g h and j, containing impurity a and d, sst mixture, containing impurity b e f g i j k and l, containing impurity a b d and e, containing impurity a e and g, containing dolutegravir 4-fluro impurity isomer 1 isomer 2 and enantiomer, for peak identification containing dolutegravir sodium and impurity a b and d, containing impurity a and d plus e, containing impurity a b c and f, containing impurity f, containing rs isomer, containing impurity a b c d e f and g, for peak identification containing impurity a and c, containing impurity mixture a mixture containing fingolimod hydrochloride fingolimod hexyl homolog fingolimod heptyl homolog o-acetyl fingolimod fingolimod nonyl homolog fingolimod decyl homolog 3-phenethyl fingolimod analog and 2-phenethyl fingolimod analog, containing impurity b, for peak identification containing impurity a b c d f g h and n, for impurity mixture containing impurity i k l and m, containing impurity b c and d, containing impurity a b and c, containing impurity a, containing impurity a b c d and j, impurity mixture containing impurity c and d, containing impurity a and e, containing impurity a b c e f g and h, containing impurity c and j, containing impurity b c e and f, for peak identification containing impurity a b c d e and f, containing impurity a e and h, containing impurity d, containing impurity a b c d and e, for peak identification containing impurity b e f h and k, for peak identification containing impurity f and j, for peak identification containing impurity b c g i and m, for peak identification containing impurity a b c f g and h, containing impurity mixture a mixture containing rosuvastatin calcium rosuvastatin ketone rosuvastatin lactone and rosuvastatin diastereomers, for peak identification containing impurity c f n o and p, containing impurity a and h, for peak performance test iprs containing impurity a and f, impurity standard (containing b c and 1 percent weight by weight impurity a, containing impurity i and h, impurity mixture containing impurity g and h, containing impurity b and c, containing impurity a b c j k and m, containing impurity d and f in Uttar pradesh.

4.
Can contractors located outside the local region participate in this bid?

Eligibility for outstation bidders depends entirely on the terms set inside the document for tender for system suitability test solution acarbose , acyclovir , amorolfine hcl , atazanavir sulphate , atenolol , beclomethasone dipropionate , bromocriptine , bromhexine , buprenorphine hcl , carvedilol tablet , chlorhexidine , clindamycin phophate , clobetasol propionate , colchicine , dolutegravir sodium , domperidone , doxycycline hcl , duloxetine , ethambutol , famotidine , finasteride , fingolimod , flurbiprofen , fusidic acid , glimepride , griserfulvin , hysoscine butyl bromide , imatinib , ketoconazole , lincomycin , loratadine , minocycline hcl , mometasone furoate , morphine , naloxone , norfloxacin , nortriptyline hcl , oxytetracycline , perindopril erbumine , pilocarpine hcl , prednisolone , progesterone , rocuronium bromide , rosuvastatin , rupatadine fumarate , salbutamol , sumatriptan , tamoxifen citrate , thiamine , tibolone , dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets , tiotropium , triamcinolone acetonide , vancomycin , venlafaxime , zuclopenthixol decanoate, system suitability test solution, containing impurity a b c d e f and g, containing impurity b j k n o and p, containing impurity d e i and j, containing impurity rs ss diastreomer special repair ss diastrreomer, containing impurity b f g i and h, containing impurity a b c l and m, containing impurity a and b, containing impurity c and d, containing impurity a b f g h and j, containing impurity a and d, sst mixture, containing impurity b e f g i j k and l, containing impurity a b d and e, containing impurity a e and g, containing dolutegravir 4-fluro impurity isomer 1 isomer 2 and enantiomer, for peak identification containing dolutegravir sodium and impurity a b and d, containing impurity a and d plus e, containing impurity a b c and f, containing impurity f, containing rs isomer, containing impurity a b c d e f and g, for peak identification containing impurity a and c, containing impurity mixture a mixture containing fingolimod hydrochloride fingolimod hexyl homolog fingolimod heptyl homolog o-acetyl fingolimod fingolimod nonyl homolog fingolimod decyl homolog 3-phenethyl fingolimod analog and 2-phenethyl fingolimod analog, containing impurity b, for peak identification containing impurity a b c d f g h and n, for impurity mixture containing impurity i k l and m, containing impurity b c and d, containing impurity a b and c, containing impurity a, containing impurity a b c d and j, impurity mixture containing impurity c and d, containing impurity a and e, containing impurity a b c e f g and h, containing impurity c and j, containing impurity b c e and f, for peak identification containing impurity a b c d e and f, containing impurity a e and h, containing impurity d, containing impurity a b c d and e, for peak identification containing impurity b e f h and k, for peak identification containing impurity f and j, for peak identification containing impurity b c g i and m, for peak identification containing impurity a b c f g and h, containing impurity mixture a mixture containing rosuvastatin calcium rosuvastatin ketone rosuvastatin lactone and rosuvastatin diastereomers, for peak identification containing impurity c f n o and p, containing impurity a and h, for peak performance test iprs containing impurity a and f, impurity standard (containing b c and 1 percent weight by weight impurity a, containing impurity i and h, impurity mixture containing impurity g and h, containing impurity b and c, containing impurity a b c j k and m, containing impurity d and f. While many public sector projects allow national competitive bidding, certain localized works require local offices or specific registration metrics in Ghaziabad.

5.
Do I need an active GeM Portal registration to apply for this work?

If this procurement is routed through the central marketplace, an active GeM Seller ID is mandatory to supply tenofovir disoproxil fumarate,buprenorphine,domperidone,doxycycline,norfloxacin,atazanavir,bromhexine,lamivudine,atenolol items. Tender18 offers complete assistance for brand cataloging, profile creation, and vendor assessment required officially by Indian pharmacopoeia commission IPC

6.
What are the primary legal documents required to submit a valid bid?

To register an eligible bid for these tenofovir disoproxil fumarate,buprenorphine,domperidone,doxycycline,norfloxacin,atazanavir,bromhexine,lamivudine,atenolol contracts, companies must prepare their core compliance documents. Vendors operating across Uttar pradesh must ensure they possess a valid GST registration, permanent account number (PAN), and active Class-3 Digital Signature Certificates.

7.
What products or services are required for this active work?

This public procurement cycle is specifically looking for qualified vendors and suppliers who can provide high-quality tenofovir disoproxil fumarate,buprenorphine,domperidone,doxycycline,norfloxacin,atazanavir,bromhexine,lamivudine,atenolol solutions. The operational execution, delivery, and deployment of these materials must be managed locally within the Ghaziabad region.

8.
Where can I review the estimated cost or budget details for this Tender?

The estimated project cost and budget thresholds can be reviewed directly inside the tender document. Bidders can analyze these qualification files to check if their firm meets the financial capability criteria specified for tender for system suitability test solution acarbose , acyclovir , amorolfine hcl , atazanavir sulphate , atenolol , beclomethasone dipropionate , bromocriptine , bromhexine , buprenorphine hcl , carvedilol tablet , chlorhexidine , clindamycin phophate , clobetasol propionate , colchicine , dolutegravir sodium , domperidone , doxycycline hcl , duloxetine , ethambutol , famotidine , finasteride , fingolimod , flurbiprofen , fusidic acid , glimepride , griserfulvin , hysoscine butyl bromide , imatinib , ketoconazole , lincomycin , loratadine , minocycline hcl , mometasone furoate , morphine , naloxone , norfloxacin , nortriptyline hcl , oxytetracycline , perindopril erbumine , pilocarpine hcl , prednisolone , progesterone , rocuronium bromide , rosuvastatin , rupatadine fumarate , salbutamol , sumatriptan , tamoxifen citrate , thiamine , tibolone , dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets , tiotropium , triamcinolone acetonide , vancomycin , venlafaxime , zuclopenthixol decanoate, system suitability test solution, containing impurity a b c d e f and g, containing impurity b j k n o and p, containing impurity d e i and j, containing impurity rs ss diastreomer special repair ss diastrreomer, containing impurity b f g i and h, containing impurity a b c l and m, containing impurity a and b, containing impurity c and d, containing impurity a b f g h and j, containing impurity a and d, sst mixture, containing impurity b e f g i j k and l, containing impurity a b d and e, containing impurity a e and g, containing dolutegravir 4-fluro impurity isomer 1 isomer 2 and enantiomer, for peak identification containing dolutegravir sodium and impurity a b and d, containing impurity a and d plus e, containing impurity a b c and f, containing impurity f, containing rs isomer, containing impurity a b c d e f and g, for peak identification containing impurity a and c, containing impurity mixture a mixture containing fingolimod hydrochloride fingolimod hexyl homolog fingolimod heptyl homolog o-acetyl fingolimod fingolimod nonyl homolog fingolimod decyl homolog 3-phenethyl fingolimod analog and 2-phenethyl fingolimod analog, containing impurity b, for peak identification containing impurity a b c d f g h and n, for impurity mixture containing impurity i k l and m, containing impurity b c and d, containing impurity a b and c, containing impurity a, containing impurity a b c d and j, impurity mixture containing impurity c and d, containing impurity a and e, containing impurity a b c e f g and h, containing impurity c and j, containing impurity b c e and f, for peak identification containing impurity a b c d e and f, containing impurity a e and h, containing impurity d, containing impurity a b c d and e, for peak identification containing impurity b e f h and k, for peak identification containing impurity f and j, for peak identification containing impurity b c g i and m, for peak identification containing impurity a b c f g and h, containing impurity mixture a mixture containing rosuvastatin calcium rosuvastatin ketone rosuvastatin lactone and rosuvastatin diastereomers, for peak identification containing impurity c f n o and p, containing impurity a and h, for peak performance test iprs containing impurity a and f, impurity standard (containing b c and 1 percent weight by weight impurity a, containing impurity i and h, impurity mixture containing impurity g and h, containing impurity b and c, containing impurity a b c j k and m, containing impurity d and f by Indian pharmacopoeia commission IPC

9.
How can I download the official BOQ file for this opportunity?

You can download the commercial Bill of Quantities (BOQ) spreadsheet directly using the secure link provided on this page. The BOQ file contains the item descriptions and rate filling forms officially validated for tender for system suitability test solution acarbose , acyclovir , amorolfine hcl , atazanavir sulphate , atenolol , beclomethasone dipropionate , bromocriptine , bromhexine , buprenorphine hcl , carvedilol tablet , chlorhexidine , clindamycin phophate , clobetasol propionate , colchicine , dolutegravir sodium , domperidone , doxycycline hcl , duloxetine , ethambutol , famotidine , finasteride , fingolimod , flurbiprofen , fusidic acid , glimepride , griserfulvin , hysoscine butyl bromide , imatinib , ketoconazole , lincomycin , loratadine , minocycline hcl , mometasone furoate , morphine , naloxone , norfloxacin , nortriptyline hcl , oxytetracycline , perindopril erbumine , pilocarpine hcl , prednisolone , progesterone , rocuronium bromide , rosuvastatin , rupatadine fumarate , salbutamol , sumatriptan , tamoxifen citrate , thiamine , tibolone , dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets , tiotropium , triamcinolone acetonide , vancomycin , venlafaxime , zuclopenthixol decanoate, system suitability test solution, containing impurity a b c d e f and g, containing impurity b j k n o and p, containing impurity d e i and j, containing impurity rs ss diastreomer special repair ss diastrreomer, containing impurity b f g i and h, containing impurity a b c l and m, containing impurity a and b, containing impurity c and d, containing impurity a b f g h and j, containing impurity a and d, sst mixture, containing impurity b e f g i j k and l, containing impurity a b d and e, containing impurity a e and g, containing dolutegravir 4-fluro impurity isomer 1 isomer 2 and enantiomer, for peak identification containing dolutegravir sodium and impurity a b and d, containing impurity a and d plus e, containing impurity a b c and f, containing impurity f, containing rs isomer, containing impurity a b c d e f and g, for peak identification containing impurity a and c, containing impurity mixture a mixture containing fingolimod hydrochloride fingolimod hexyl homolog fingolimod heptyl homolog o-acetyl fingolimod fingolimod nonyl homolog fingolimod decyl homolog 3-phenethyl fingolimod analog and 2-phenethyl fingolimod analog, containing impurity b, for peak identification containing impurity a b c d f g h and n, for impurity mixture containing impurity i k l and m, containing impurity b c and d, containing impurity a b and c, containing impurity a, containing impurity a b c d and j, impurity mixture containing impurity c and d, containing impurity a and e, containing impurity a b c e f g and h, containing impurity c and j, containing impurity b c e and f, for peak identification containing impurity a b c d e and f, containing impurity a e and h, containing impurity d, containing impurity a b c d and e, for peak identification containing impurity b e f h and k, for peak identification containing impurity f and j, for peak identification containing impurity b c g i and m, for peak identification containing impurity a b c f g and h, containing impurity mixture a mixture containing rosuvastatin calcium rosuvastatin ketone rosuvastatin lactone and rosuvastatin diastereomers, for peak identification containing impurity c f n o and p, containing impurity a and h, for peak performance test iprs containing impurity a and f, impurity standard (containing b c and 1 percent weight by weight impurity a, containing impurity i and h, impurity mixture containing impurity g and h, containing impurity b and c, containing impurity a b c j k and m, containing impurity d and f within the Uttar pradesh jurisdiction

10.
How can I find the submission closing date for this contract?

The official timeline and deadline details for tender for system suitability test solution acarbose , acyclovir , amorolfine hcl , atazanavir sulphate , atenolol , beclomethasone dipropionate , bromocriptine , bromhexine , buprenorphine hcl , carvedilol tablet , chlorhexidine , clindamycin phophate , clobetasol propionate , colchicine , dolutegravir sodium , domperidone , doxycycline hcl , duloxetine , ethambutol , famotidine , finasteride , fingolimod , flurbiprofen , fusidic acid , glimepride , griserfulvin , hysoscine butyl bromide , imatinib , ketoconazole , lincomycin , loratadine , minocycline hcl , mometasone furoate , morphine , naloxone , norfloxacin , nortriptyline hcl , oxytetracycline , perindopril erbumine , pilocarpine hcl , prednisolone , progesterone , rocuronium bromide , rosuvastatin , rupatadine fumarate , salbutamol , sumatriptan , tamoxifen citrate , thiamine , tibolone , dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets , tiotropium , triamcinolone acetonide , vancomycin , venlafaxime , zuclopenthixol decanoate, system suitability test solution, containing impurity a b c d e f and g, containing impurity b j k n o and p, containing impurity d e i and j, containing impurity rs ss diastreomer special repair ss diastrreomer, containing impurity b f g i and h, containing impurity a b c l and m, containing impurity a and b, containing impurity c and d, containing impurity a b f g h and j, containing impurity a and d, sst mixture, containing impurity b e f g i j k and l, containing impurity a b d and e, containing impurity a e and g, containing dolutegravir 4-fluro impurity isomer 1 isomer 2 and enantiomer, for peak identification containing dolutegravir sodium and impurity a b and d, containing impurity a and d plus e, containing impurity a b c and f, containing impurity f, containing rs isomer, containing impurity a b c d e f and g, for peak identification containing impurity a and c, containing impurity mixture a mixture containing fingolimod hydrochloride fingolimod hexyl homolog fingolimod heptyl homolog o-acetyl fingolimod fingolimod nonyl homolog fingolimod decyl homolog 3-phenethyl fingolimod analog and 2-phenethyl fingolimod analog, containing impurity b, for peak identification containing impurity a b c d f g h and n, for impurity mixture containing impurity i k l and m, containing impurity b c and d, containing impurity a b and c, containing impurity a, containing impurity a b c d and j, impurity mixture containing impurity c and d, containing impurity a and e, containing impurity a b c e f g and h, containing impurity c and j, containing impurity b c e and f, for peak identification containing impurity a b c d e and f, containing impurity a e and h, containing impurity d, containing impurity a b c d and e, for peak identification containing impurity b e f h and k, for peak identification containing impurity f and j, for peak identification containing impurity b c g i and m, for peak identification containing impurity a b c f g and h, containing impurity mixture a mixture containing rosuvastatin calcium rosuvastatin ketone rosuvastatin lactone and rosuvastatin diastereomers, for peak identification containing impurity c f n o and p, containing impurity a and h, for peak performance test iprs containing impurity a and f, impurity standard (containing b c and 1 percent weight by weight impurity a, containing impurity i and h, impurity mixture containing impurity g and h, containing impurity b and c, containing impurity a b c j k and m, containing impurity d and f are available inside the detailed notification files. Bidders planning to target this contract in Ghaziabad should check the official portal schedule early to complete their online technical and financial submission well before the closing hours.

GeM Registration Services By State
GeM Andhra Pradesh|GeM Assam|GeM Chandigarh|GeM Delhi|GeM Gujarat|GeM Himachal Pradesh|GeM Jharkhand|GeM Ladakh|GeM Maharashtra|GeM Puducherry|View All
GeM Registration Services By City
GeM Ahmedabad|GeM Mumbai|GeM New Delhi|GeM Hyderabad|GeM Chennai|GeM Kolkata|GeM Pune|GeM Jaipur|GeM Kanpur|GeM Indore|GeM Patna|GeM Nashik|GeM Varanasi|GeM Ranchi|GeM Coimbatore|GeM Amritsar|GeM Hubli|View All